Cantitate/Preț
Produs

Cancer Targeting Therapies

Editat de Muhammad Yasir Ali, Shazia Bukhari
en Limba Engleză Paperback – 19 dec 2024
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 22023 lei  3-5 săpt. +2004 lei  7-13 zile
  CRC Press – 19 dec 2024 22023 lei  3-5 săpt. +2004 lei  7-13 zile
Hardback (1) 57412 lei  3-5 săpt. +3045 lei  7-13 zile
  CRC Press – 30 sep 2023 57412 lei  3-5 săpt. +3045 lei  7-13 zile

Preț: 22023 lei

Preț vechi: 23182 lei
-5% Nou

Puncte Express: 330

Preț estimativ în valută:
4215 4395$ 3503£

Carte disponibilă

Livrare economică 27 februarie-13 martie
Livrare express 13-19 februarie pentru 3003 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032427126
ISBN-10: 1032427124
Pagini: 296
Dimensiuni: 178 x 254 x 17 mm
Greutate: 0.55 kg
Editura: CRC Press

Cuprins

    1. History of Cancer Therapies
    2. Cancer and Carcinogens
    3. Causes of Death from Cancer
    4. Passive Targeting
    5. Cancer Active Targeting Strategies
      Conventional Cancer Therapies

    6. Oral Anticancer Therapies
    7. Parenteral Anticancer Therapies
      Advanced Cancer Therapies

    8. The Advent of Micro and Nano-spheres for Cancer Treatment
    9. The Emergence of Liposomes in Cancer Therapy
    10. Niosomes-Based Anticancer Therapies
    11. Solid Lipid Nanoparticles-Based Anticancer Therapies
    12. Mesoporous Nanoparticles-Based Anticancer Therapies
    13. Antibody-Based Cancer Therapies
    14. Aptamer-Based Anticancer Therapies
    15. Polyamidoamines-Based Anticancer Therapies
    16. Photodynamic Therapies for Cancer Treatment

Notă biografică

Dr. Muhammad Yasir Ali
My pharmacy career started back in 2002 as a graduate student, leading to the achievement of a graduate and then a master's degree in Pharmaceutical Technology in 2009. Nevertheless, with my thirst for knowledge as a student and researcher, an in-line experience in production and quality control in Roche Pakistan helped me in knowing the ropes of the subject.
Later on, I joined the university of Lahore as a faculty member and taught different courses to pharmacy graduates, especially pharmaceutical technology. In 2011 after joining my current job, I kept on teaching and indulged myself in research which is still going on, meanwhile, I got my doctorate (Pharmaceutical Technology) from Germany.
I have more than 30 research publications, one research project, practical application of pharmacy knowledge in the form of different marketed products, several book chapters, and one book as editor in my research basket. I got chances of presenting research papers and scientific lectures in different organizations in Germany, USA, UK, and Pakistan.
Dr. Shazia Bukhari
I completed my undergraduate studies from the Bahuddin Zakariya University, Multan (1998-2001) and my M.Phil. studies from the Department of Biochemistry, University of Agriculture, Faisalabad Pakistan (2001-2003). Then I continued higher studies in Punjab University and earned Ph.D. degree in Biochemistry (2005-2009).
I started my career at Hi-Tech Lab, University of Agriculture, Faisalabad (2003 – 2004). Then I joined Center for Agricultural Biochemistry and Biotechnology (CABB), University of Agriculture, Faisalabad as Research Officer/Lecturer (2004-2011). Then I joined Government College University as Assistant Professor (2011-2014). I was promoted to Associate Professor (2014-2019 and Professor (2019 to date) in the Department of Biochemistry of the same university.
My research interest focuses on the exploration of indigenous flora for treatment of various diseases, based on an understanding of the mechanisms underlying the successful interactions between the plant components and disease. For this purpose, we are now using computational tools to correlate the laboratory findings with computer modeling. I am also working to enhance resistance of wheat (Triticum aestivum) against fungus diseases like rust. For this purpose, we have been transforming rust resistance and Pathogenesis-Related genes, isolated from local verities, and transform into high yielding wheat commercial varieties. I have screened and characterized nine novel genes relating rust resistance and pathogenesis related and deposited in gene bank. I am currently running two projects for achieving this goal approved by HEC: 3.679,655 million) as PI and 2nd approved by Technology Development Funds. HEC (13.609 million) as PI.